Related Experiment Videos
Platelet activating factor antagonist activity of ginsenosides
1Natural Product Biosynthesis Research Unit, Korea Research Institute of Bioscience & Biotechnology, Taejon.
Biological & Pharmaceutical Bulletin
|February 26, 1998
Summary
Certain ginseng saponins, specifically 20(S)- and delta20-ginsenosides Rg3, show potential as platelet activating factor (PAF) antagonists. These compounds may offer therapeutic benefits by blocking PAF receptor interactions.
Area of Science:
- Pharmacology
- Natural Products Chemistry
- Biochemistry
Background:
- Platelet activating factor (PAF) is a potent lipid mediator involved in inflammatory and allergic responses.
- Ginseng saponins are bioactive compounds found in Panax ginseng with diverse pharmacological properties.
- Understanding the interactions between natural compounds and PAF is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To screen ginseng saponins and their degradation products for antagonist activity against platelet activating factor (PAF).
- To identify specific ginsenosides that can inhibit the binding of PAF to its receptor.
Main Methods:
- Washed rabbit platelets were used for receptor binding studies.
- Radio-labeled [3H]PAF was employed to quantify receptor binding.
- The inhibitory concentration 50 (IC50) values were determined for active compounds.
Main Results:
- 20(S)-ginsenoside Rg3 and delta20-ginsenoside Rg3, both protopanaxadiol-type saponins, demonstrated significant PAF antagonist activity.
- The IC50 values for these ginsenosides were 4.9 x 10(-5) M and 9.2 x 10(-5) M, respectively.
- These findings highlight the specific anti-PAF properties of certain ginsenosides.
Conclusions:
- Ginsenosides Rg3 isomers are effective antagonists of platelet activating factor (PAF).
- These compounds represent potential therapeutic agents for conditions mediated by PAF.
- Further research into the mechanism and in vivo efficacy of these ginsenosides is warranted.